S 5502 — 119th Congress

Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act

Introduced Sep 24, 2026 Open for voting
Note: Bill summaries and components on this page are AI-generated and may contain errors. Always consult the original bill text and official sources before relying on this information.
← Open legislation
Click Vote to enable simultaneous voting.

Core Policy Mechanism Top 1

CISA Authority Over Biotech/Biomanufacturing Infrastructure

Expands the Cybersecurity and Infrastructure Security Agency (CISA) mission to explicitly cover biotechnology and biomanufacturing facilities that have no other designated federal sector protector, requiring dedicated staff, outreach, assessments, and a national protection plan. Requires the Cybersecurity and Infrastructure Security Agency (CISA) Director to submit a work plan within 45 days, a follow-up implementation report within one year, and a gap assessment on unprotected critical biotech areas within two years.

  • Population Scope Low The provision directly affects a narrow set of biotechnology and biomanufacturing facility owners and operators lacking a designated sector-specific agency, a small fraction of U.S. entities.
  • Budgetary Magnitude Low No funds are authorized or appropriated; the bill imposes duties on the Cybersecurity and Infrastructure Security Agency (CISA) without any accompanying spending authority.
  • Legal / Regulatory Depth Medium The bill creates new statutory mandates on CISA — designated staff, coordinated assessments, outreach, and a national plan — that bind agency conduct toward a previously unaddressed sector, which is a procedural-to-structural shift rather than a change in substantive rights or prohibitions across the regulated population.
  • Degree of Discretion Granted Medium The bill uses mandatory 'shall' language for core duties but leaves CISA considerable latitude in how to designate staff, conduct outreach, and structure the national plan, including 'as appropriate' qualifiers on convening sector agencies.
  • Implementation & Enforcement Burden Low No new enforcement mechanisms, penalties, or compliance obligations are imposed on private entities; the burden falls entirely on CISA as an internal administrative coordination and reporting obligation.
  • Temporal Commitment High The statutory amendments to 6 U.S.C. § 652 are permanent with no expiry or reauthorization trigger, binding CISA indefinitely unless Congress acts to repeal them.
No signal yet

No possible riders have been surfaced for this bill.

Summary

This bill directs the Cybersecurity and Infrastructure Security Agency (CISA) of the Department of Homeland Security (DHS) to treat biotechnology and biomanufacturing as critical infrastructure. It amends existing homeland security law to require CISA to protect biotech and biomanufacturing facilities that lack a designated sector-specific agency, coordinate with industry groups, and develop security plans. CISA must also submit a work plan, an implementation report, and a report on gaps in biotech protection to Congress.

AI-generated summary, pending human review.

Full bill text rendering is coming soon.

In the meantime, read the full text on Congress.gov ↗.

Version Event Date User support Your vote Roll calls
Original
Initial publication
Sep 24, 2026
Sep 24, 2026 No votes yet — —

Core Policy Mechanism Top 1

CISA Authority Over Biotech/Biomanufacturing Infrastructure

Expands the Cybersecurity and Infrastructure Security Agency (CISA) mission to explicitly cover biotechnology and biomanufacturing facilities that have no other designated federal sector protector, requiring dedicated staff, outreach, assessments, and a national protection plan. Requires the Cybersecurity and Infrastructure Security Agency (CISA) Director to submit a work plan within 45 days, a follow-up implementation report within one year, and a gap assessment on unprotected critical biotech areas within two years.

  • Population Scope Low The provision directly affects a narrow set of biotechnology and biomanufacturing facility owners and operators lacking a designated sector-specific agency, a small fraction of U.S. entities.
  • Budgetary Magnitude Low No funds are authorized or appropriated; the bill imposes duties on the Cybersecurity and Infrastructure Security Agency (CISA) without any accompanying spending authority.
  • Legal / Regulatory Depth Medium The bill creates new statutory mandates on CISA — designated staff, coordinated assessments, outreach, and a national plan — that bind agency conduct toward a previously unaddressed sector, which is a procedural-to-structural shift rather than a change in substantive rights or prohibitions across the regulated population.
  • Degree of Discretion Granted Medium The bill uses mandatory 'shall' language for core duties but leaves CISA considerable latitude in how to designate staff, conduct outreach, and structure the national plan, including 'as appropriate' qualifiers on convening sector agencies.
  • Implementation & Enforcement Burden Low No new enforcement mechanisms, penalties, or compliance obligations are imposed on private entities; the burden falls entirely on CISA as an internal administrative coordination and reporting obligation.
  • Temporal Commitment High The statutory amendments to 6 U.S.C. § 652 are permanent with no expiry or reauthorization trigger, binding CISA indefinitely unless Congress acts to repeal them.
No signal yet

Core Policy Mechanism

CISA Authority Over Biotech/Biomanufacturing Infrastructure